Non‐acral skin manifestations during the COVID‐19 epidemic: COVIDSKIN study by the French Society of Dermatology
A variety of skin manifestations occurring during the COVID-19 pandemic have been reported since March 2020.1 The most reported were chilblain-like lesions, widespread urticaria, maculopapular eruptions, vesicular eruptions and vascular lesions such as livedo or necrosis..
Gespeichert in:
| Veröffentlicht in: | Journal of the European Academy of Dermatology and Venereology 2021-09, Vol.35 (9), p.e539-e541 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e541 |
|---|---|
| container_issue | 9 |
| container_start_page | e539 |
| container_title | Journal of the European Academy of Dermatology and Venereology |
| container_volume | 35 |
| creator | Guelimi, R. Salle, R. Dousset, L. Assier, H. Fourati, S. Bhujoo, Z. Barbarot, S. Boulard, C. Cazanave, C. Colin, A. Kostrzewa, E. Lesort, C. Levy Roy, A. Lombart, F. Marco Bonnet, J. Marty, L. Monfort, J.B. Riffaud, L. Samimi, M. Tardieu, M. Sbidian, E. Wolkenstein, P. Le Cleach, L. Beylot‐Barry, M. |
| description | A variety of skin manifestations occurring during the COVID-19 pandemic have been reported since March 2020.1 The most reported were chilblain-like lesions, widespread urticaria, maculopapular eruptions, vesicular eruptions and vascular lesions such as livedo or necrosis.. |
| doi_str_mv | 10.1111/jdv.17322 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8242387</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2520872374</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4492-5527cbd25ecd9d8ec93403cf153b3c6023e7ae488f9b1c237b20aa2aac0f54253</originalsourceid><addsrcrecordid>eNp1kctu1DAUhi0EokNhwQsgL2GR1teJzQKpmqF0YNQuCt1ajuPMuCT2YCeDsuMReEaeBLcp5SLhjaXjz9_x8Q_Ac4yOcF7H1_X-CJeUkAdghtlcFBQJ-hDMkCTzQkouD8CTlK4RQhhz8RgcUCoxkyWfgf48-B_fvmsTdQvTZ-dhp71rbOp174JPsB6i8xvYby1cXFytlhnGEtqdq23nzOupePlhdQ5TP9QjrMZb9jRab7bwMhhn-xGGBi5t7HQf2rAZn4JHjW6TfXa3H4JPp28_Ls6K9cW71eJkXRjGJCk4J6WpasKtqWUtrJGUIWoazGlFzRwRakttmRCNrLAhtKwI0ppobVDDGeH0ELyZvLuh6mxtrO_zmGoXXafjqIJ26u8T77ZqE_ZKEEaoKLPg1STY_nPt7GStbmqIEsyJRHuc2Zd3zWL4MuQPVJ1Lxrat9jYMSRFOkCjzK9lvrYkhpWibezdG6iZRlRNVt4lm9sWfM9yTvyLMwPEEfHWtHf9vUu-XV5PyJ4I2rHg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2520872374</pqid></control><display><type>article</type><title>Non‐acral skin manifestations during the COVID‐19 epidemic: COVIDSKIN study by the French Society of Dermatology</title><source>Wiley Online Library All Journals</source><creator>Guelimi, R. ; Salle, R. ; Dousset, L. ; Assier, H. ; Fourati, S. ; Bhujoo, Z. ; Barbarot, S. ; Boulard, C. ; Cazanave, C. ; Colin, A. ; Kostrzewa, E. ; Lesort, C. ; Levy Roy, A. ; Lombart, F. ; Marco Bonnet, J. ; Marty, L. ; Monfort, J.B. ; Riffaud, L. ; Samimi, M. ; Tardieu, M. ; Sbidian, E. ; Wolkenstein, P. ; Le Cleach, L. ; Beylot‐Barry, M.</creator><creatorcontrib>Guelimi, R. ; Salle, R. ; Dousset, L. ; Assier, H. ; Fourati, S. ; Bhujoo, Z. ; Barbarot, S. ; Boulard, C. ; Cazanave, C. ; Colin, A. ; Kostrzewa, E. ; Lesort, C. ; Levy Roy, A. ; Lombart, F. ; Marco Bonnet, J. ; Marty, L. ; Monfort, J.B. ; Riffaud, L. ; Samimi, M. ; Tardieu, M. ; Sbidian, E. ; Wolkenstein, P. ; Le Cleach, L. ; Beylot‐Barry, M.</creatorcontrib><description>A variety of skin manifestations occurring during the COVID-19 pandemic have been reported since March 2020.1 The most reported were chilblain-like lesions, widespread urticaria, maculopapular eruptions, vesicular eruptions and vascular lesions such as livedo or necrosis..</description><identifier>ISSN: 0926-9959</identifier><identifier>EISSN: 1468-3083</identifier><identifier>DOI: 10.1111/jdv.17322</identifier><identifier>PMID: 33914975</identifier><language>eng</language><publisher>England: Wiley</publisher><subject>Covid‐19 Special Forum ; Dermatology ; Human health and pathology ; Letter to the Editor ; Life Sciences</subject><ispartof>Journal of the European Academy of Dermatology and Venereology, 2021-09, Vol.35 (9), p.e539-e541</ispartof><rights>2021 European Academy of Dermatology and Venereology</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4492-5527cbd25ecd9d8ec93403cf153b3c6023e7ae488f9b1c237b20aa2aac0f54253</citedby><cites>FETCH-LOGICAL-c4492-5527cbd25ecd9d8ec93403cf153b3c6023e7ae488f9b1c237b20aa2aac0f54253</cites><orcidid>0000-0002-5678-1614 ; 0000-0002-4044-0727 ; 0000-0001-6150-1229 ; 0000-0002-4792-2622 ; 0000-0002-6629-9100 ; 0000-0002-1267-5270 ; 0000-0003-1385-6839</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjdv.17322$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjdv.17322$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33914975$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.inrae.fr/hal-03215290$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Guelimi, R.</creatorcontrib><creatorcontrib>Salle, R.</creatorcontrib><creatorcontrib>Dousset, L.</creatorcontrib><creatorcontrib>Assier, H.</creatorcontrib><creatorcontrib>Fourati, S.</creatorcontrib><creatorcontrib>Bhujoo, Z.</creatorcontrib><creatorcontrib>Barbarot, S.</creatorcontrib><creatorcontrib>Boulard, C.</creatorcontrib><creatorcontrib>Cazanave, C.</creatorcontrib><creatorcontrib>Colin, A.</creatorcontrib><creatorcontrib>Kostrzewa, E.</creatorcontrib><creatorcontrib>Lesort, C.</creatorcontrib><creatorcontrib>Levy Roy, A.</creatorcontrib><creatorcontrib>Lombart, F.</creatorcontrib><creatorcontrib>Marco Bonnet, J.</creatorcontrib><creatorcontrib>Marty, L.</creatorcontrib><creatorcontrib>Monfort, J.B.</creatorcontrib><creatorcontrib>Riffaud, L.</creatorcontrib><creatorcontrib>Samimi, M.</creatorcontrib><creatorcontrib>Tardieu, M.</creatorcontrib><creatorcontrib>Sbidian, E.</creatorcontrib><creatorcontrib>Wolkenstein, P.</creatorcontrib><creatorcontrib>Le Cleach, L.</creatorcontrib><creatorcontrib>Beylot‐Barry, M.</creatorcontrib><title>Non‐acral skin manifestations during the COVID‐19 epidemic: COVIDSKIN study by the French Society of Dermatology</title><title>Journal of the European Academy of Dermatology and Venereology</title><addtitle>J Eur Acad Dermatol Venereol</addtitle><description>A variety of skin manifestations occurring during the COVID-19 pandemic have been reported since March 2020.1 The most reported were chilblain-like lesions, widespread urticaria, maculopapular eruptions, vesicular eruptions and vascular lesions such as livedo or necrosis..</description><subject>Covid‐19 Special Forum</subject><subject>Dermatology</subject><subject>Human health and pathology</subject><subject>Letter to the Editor</subject><subject>Life Sciences</subject><issn>0926-9959</issn><issn>1468-3083</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp1kctu1DAUhi0EokNhwQsgL2GR1teJzQKpmqF0YNQuCt1ajuPMuCT2YCeDsuMReEaeBLcp5SLhjaXjz9_x8Q_Ac4yOcF7H1_X-CJeUkAdghtlcFBQJ-hDMkCTzQkouD8CTlK4RQhhz8RgcUCoxkyWfgf48-B_fvmsTdQvTZ-dhp71rbOp174JPsB6i8xvYby1cXFytlhnGEtqdq23nzOupePlhdQ5TP9QjrMZb9jRab7bwMhhn-xGGBi5t7HQf2rAZn4JHjW6TfXa3H4JPp28_Ls6K9cW71eJkXRjGJCk4J6WpasKtqWUtrJGUIWoazGlFzRwRakttmRCNrLAhtKwI0ppobVDDGeH0ELyZvLuh6mxtrO_zmGoXXafjqIJ26u8T77ZqE_ZKEEaoKLPg1STY_nPt7GStbmqIEsyJRHuc2Zd3zWL4MuQPVJ1Lxrat9jYMSRFOkCjzK9lvrYkhpWibezdG6iZRlRNVt4lm9sWfM9yTvyLMwPEEfHWtHf9vUu-XV5PyJ4I2rHg</recordid><startdate>202109</startdate><enddate>202109</enddate><creator>Guelimi, R.</creator><creator>Salle, R.</creator><creator>Dousset, L.</creator><creator>Assier, H.</creator><creator>Fourati, S.</creator><creator>Bhujoo, Z.</creator><creator>Barbarot, S.</creator><creator>Boulard, C.</creator><creator>Cazanave, C.</creator><creator>Colin, A.</creator><creator>Kostrzewa, E.</creator><creator>Lesort, C.</creator><creator>Levy Roy, A.</creator><creator>Lombart, F.</creator><creator>Marco Bonnet, J.</creator><creator>Marty, L.</creator><creator>Monfort, J.B.</creator><creator>Riffaud, L.</creator><creator>Samimi, M.</creator><creator>Tardieu, M.</creator><creator>Sbidian, E.</creator><creator>Wolkenstein, P.</creator><creator>Le Cleach, L.</creator><creator>Beylot‐Barry, M.</creator><general>Wiley</general><general>John Wiley and Sons Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5678-1614</orcidid><orcidid>https://orcid.org/0000-0002-4044-0727</orcidid><orcidid>https://orcid.org/0000-0001-6150-1229</orcidid><orcidid>https://orcid.org/0000-0002-4792-2622</orcidid><orcidid>https://orcid.org/0000-0002-6629-9100</orcidid><orcidid>https://orcid.org/0000-0002-1267-5270</orcidid><orcidid>https://orcid.org/0000-0003-1385-6839</orcidid></search><sort><creationdate>202109</creationdate><title>Non‐acral skin manifestations during the COVID‐19 epidemic: COVIDSKIN study by the French Society of Dermatology</title><author>Guelimi, R. ; Salle, R. ; Dousset, L. ; Assier, H. ; Fourati, S. ; Bhujoo, Z. ; Barbarot, S. ; Boulard, C. ; Cazanave, C. ; Colin, A. ; Kostrzewa, E. ; Lesort, C. ; Levy Roy, A. ; Lombart, F. ; Marco Bonnet, J. ; Marty, L. ; Monfort, J.B. ; Riffaud, L. ; Samimi, M. ; Tardieu, M. ; Sbidian, E. ; Wolkenstein, P. ; Le Cleach, L. ; Beylot‐Barry, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4492-5527cbd25ecd9d8ec93403cf153b3c6023e7ae488f9b1c237b20aa2aac0f54253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Covid‐19 Special Forum</topic><topic>Dermatology</topic><topic>Human health and pathology</topic><topic>Letter to the Editor</topic><topic>Life Sciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Guelimi, R.</creatorcontrib><creatorcontrib>Salle, R.</creatorcontrib><creatorcontrib>Dousset, L.</creatorcontrib><creatorcontrib>Assier, H.</creatorcontrib><creatorcontrib>Fourati, S.</creatorcontrib><creatorcontrib>Bhujoo, Z.</creatorcontrib><creatorcontrib>Barbarot, S.</creatorcontrib><creatorcontrib>Boulard, C.</creatorcontrib><creatorcontrib>Cazanave, C.</creatorcontrib><creatorcontrib>Colin, A.</creatorcontrib><creatorcontrib>Kostrzewa, E.</creatorcontrib><creatorcontrib>Lesort, C.</creatorcontrib><creatorcontrib>Levy Roy, A.</creatorcontrib><creatorcontrib>Lombart, F.</creatorcontrib><creatorcontrib>Marco Bonnet, J.</creatorcontrib><creatorcontrib>Marty, L.</creatorcontrib><creatorcontrib>Monfort, J.B.</creatorcontrib><creatorcontrib>Riffaud, L.</creatorcontrib><creatorcontrib>Samimi, M.</creatorcontrib><creatorcontrib>Tardieu, M.</creatorcontrib><creatorcontrib>Sbidian, E.</creatorcontrib><creatorcontrib>Wolkenstein, P.</creatorcontrib><creatorcontrib>Le Cleach, L.</creatorcontrib><creatorcontrib>Beylot‐Barry, M.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of the European Academy of Dermatology and Venereology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Guelimi, R.</au><au>Salle, R.</au><au>Dousset, L.</au><au>Assier, H.</au><au>Fourati, S.</au><au>Bhujoo, Z.</au><au>Barbarot, S.</au><au>Boulard, C.</au><au>Cazanave, C.</au><au>Colin, A.</au><au>Kostrzewa, E.</au><au>Lesort, C.</au><au>Levy Roy, A.</au><au>Lombart, F.</au><au>Marco Bonnet, J.</au><au>Marty, L.</au><au>Monfort, J.B.</au><au>Riffaud, L.</au><au>Samimi, M.</au><au>Tardieu, M.</au><au>Sbidian, E.</au><au>Wolkenstein, P.</au><au>Le Cleach, L.</au><au>Beylot‐Barry, M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Non‐acral skin manifestations during the COVID‐19 epidemic: COVIDSKIN study by the French Society of Dermatology</atitle><jtitle>Journal of the European Academy of Dermatology and Venereology</jtitle><addtitle>J Eur Acad Dermatol Venereol</addtitle><date>2021-09</date><risdate>2021</risdate><volume>35</volume><issue>9</issue><spage>e539</spage><epage>e541</epage><pages>e539-e541</pages><issn>0926-9959</issn><eissn>1468-3083</eissn><abstract>A variety of skin manifestations occurring during the COVID-19 pandemic have been reported since March 2020.1 The most reported were chilblain-like lesions, widespread urticaria, maculopapular eruptions, vesicular eruptions and vascular lesions such as livedo or necrosis..</abstract><cop>England</cop><pub>Wiley</pub><pmid>33914975</pmid><doi>10.1111/jdv.17322</doi><tpages>0</tpages><orcidid>https://orcid.org/0000-0002-5678-1614</orcidid><orcidid>https://orcid.org/0000-0002-4044-0727</orcidid><orcidid>https://orcid.org/0000-0001-6150-1229</orcidid><orcidid>https://orcid.org/0000-0002-4792-2622</orcidid><orcidid>https://orcid.org/0000-0002-6629-9100</orcidid><orcidid>https://orcid.org/0000-0002-1267-5270</orcidid><orcidid>https://orcid.org/0000-0003-1385-6839</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0926-9959 |
| ispartof | Journal of the European Academy of Dermatology and Venereology, 2021-09, Vol.35 (9), p.e539-e541 |
| issn | 0926-9959 1468-3083 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8242387 |
| source | Wiley Online Library All Journals |
| subjects | Covid‐19 Special Forum Dermatology Human health and pathology Letter to the Editor Life Sciences |
| title | Non‐acral skin manifestations during the COVID‐19 epidemic: COVIDSKIN study by the French Society of Dermatology |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T14%3A57%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Non%E2%80%90acral%20skin%20manifestations%20during%20the%20COVID%E2%80%9019%20epidemic:%20COVIDSKIN%20study%20by%20the%20French%20Society%20of%20Dermatology&rft.jtitle=Journal%20of%20the%20European%20Academy%20of%20Dermatology%20and%20Venereology&rft.au=Guelimi,%20R.&rft.date=2021-09&rft.volume=35&rft.issue=9&rft.spage=e539&rft.epage=e541&rft.pages=e539-e541&rft.issn=0926-9959&rft.eissn=1468-3083&rft_id=info:doi/10.1111/jdv.17322&rft_dat=%3Cproquest_pubme%3E2520872374%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2520872374&rft_id=info:pmid/33914975&rfr_iscdi=true |